2019 Nov 21;381(21):1995-2008
Global dealmaking surged past the $3 trillion mark in the first nine months of 2025, lifted by a 33% surge in U.S
has received consulting fees on behalf of Newcastle University from 89bio, Akero, Alimentiv, AstraZeneca, Axcella, Boehringer Ingelheim, Bristol Myers Squibb, Galmed, Genentech, Genfit, Gilead, GlaxoSmithKline, Hanmi, HistoIndex, Intercept, Inventiva, Ionis, IQVIA, Janssen, Madrigal, Medpace, Merck, NGMBio, Novartis, Novo Nordisk, PathAI, Pfizer, Pharmanest, Poxel, Prosciento, Resolution Therapeutics, Ridgeline Therapeutics, Roche, RTI, Shionogi and Terns Pharmaceuticals
Botta said thats eroded the economics of compounding
2013;37(12):113256 Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J
Selak et al